{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:53:50Z","timestamp":1772121230238,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005071","name":"Shiraz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.meegid.2021.105136","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T22:49:18Z","timestamp":1636670958000},"page":"105136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases"],"prefix":"10.1016","volume":"96","author":[{"given":"Hesam","family":"Dorosti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedigheh","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboubeh","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Nezafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younes","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2021.105136_bb0005","first-page":"1217","article-title":"Expression of the L2 and E7 genes of the human papillomavirus type 16 in female genital dysplasias","volume":"141","author":"Auvinen","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.meegid.2021.105136_bb0010","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1469-0691.2011.03604.x","article-title":"Intracellular bacteria and adverse pregnancy outcomes","volume":"17","author":"Baud","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2021.105136_bb0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/infdis\/jit651","article-title":"Correlate of immune protection against HSV-1 genital disease in vaccinated women","volume":"209","author":"Belshe","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.105136_bb0020","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/429240","article-title":"Safety and immunogenicity of glycoprotein D\u2014adjuvant genital herpes vaccine","volume":"40","author":"Bernstein","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.105136_bb0025","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.vaccine.2014.01.053","article-title":"Vaccines against sexually transmitted infections: the way forward","volume":"32","author":"Broutet","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.105136_bb0030","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2021.105136_bb0035","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/hum.2017.197","article-title":"Therapeutic DNA vaccines for human papillomavirus and associated diseases","volume":"29","author":"Cheng","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.meegid.2021.105136_bb0040","series-title":"An Introduction to Hydrogen Bonding By George A. Jeffrey (University of Pittsburgh)","author":"Dannenberg","year":"1998"},{"key":"10.1016\/j.meegid.2021.105136_bb0045","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2 \u2013 a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.meegid.2021.105136_bb0050","doi-asserted-by":"crossref","first-page":"101446","DOI":"10.1016\/j.mcp.2019.101446","article-title":"Designing self-assembled peptide nanovaccine against Streptococcus pneumoniae: an in silico strategy","volume":"48","author":"Dorosti","year":"2019","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.meegid.2021.105136_bb0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1875035400801010022","article-title":"Bioinformatic approach for identifying parasite and fungal candidate subunit vaccines","volume":"1","author":"Doytchinova","year":"2008","journal-title":"Open Vaccine J."},{"key":"10.1016\/j.meegid.2021.105136_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s42269-019-0227-2","article-title":"Toll-like receptors activation, signaling, and targeting: an overview","volume":"43","author":"El-Zayat","year":"2019","journal-title":"Bull. Natl. Res. Centre"},{"key":"10.1016\/j.meegid.2021.105136_bb0065","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/humrep\/deh775","article-title":"Characterization of toll-like receptors in the female reproductive tract in humans","volume":"20","author":"Fazeli","year":"2005","journal-title":"Hum, Reprod, (Oxford, England)"},{"key":"10.1016\/j.meegid.2021.105136_bb0070","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.meegid.2021.105136_bb0075","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.meegid.2021.105136_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QCO.0000000000000343","article-title":"Future prospects for new vaccines against sexually transmitted infections","volume":"30","author":"Gottlieb","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.105136_bb0085","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.vaccine.2016.03.111","article-title":"The global roadmap for advancing development of vaccines against sexually transmitted infections: update and next steps","volume":"34","author":"Gottlieb","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.105136_bb0090","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1093\/nar\/gkg510","article-title":"MHCPred: a server for quantitative prediction of peptide-MHC binding","volume":"31","author":"Guan","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2021.105136_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/ijpvm.IJPVM_413_16","article-title":"Efficacy of human papillomavirus L1 protein vaccines (Cervarix and Gardasil) in reducing the risk of cervical intraepithelial neoplasia: a meta-analysis","volume":"8","author":"Haghshenas","year":"2017","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.meegid.2021.105136_bb0100","first-page":"3098","article-title":"Protein\u2013sol: a web tool for predicting protein solubility from sequence","volume":"33","author":"Hebditch","year":"2017","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.meegid.2021.105136_bb0105","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2021.105136_bb0110","doi-asserted-by":"crossref","first-page":"32153","DOI":"10.1038\/srep32153","article-title":"GalaxyRefineComplex: refinement of protein-protein complex model structures driven by interface repacking","volume":"6","author":"Heo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2021.105136_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007095","article-title":"Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in Guinea pigs","volume":"14","author":"Hook","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2021.105136_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188934","article-title":"Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells","volume":"12","author":"Ito","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.105136_bb0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.meegid.2021.105136_bb0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.meegid.2021.105136_bb0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/infdis\/jiy497","article-title":"The burden of human papillomavirus and chlamydia trachomatis coinfection in women: a large cohort study in inner Mongolia, China","volume":"219","author":"Ji","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.105136_bb0140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1586\/14760584.2016.1157479","article-title":"Progress and prospects for L2-based human papillomavirus vaccines","volume":"15","author":"Jiang","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.meegid.2021.105136_bb0145","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4049\/jimmunol.1502366","article-title":"Extensive CD4 and CD8 T cell cross-reactivity between alphaherpesviruses","volume":"196","author":"Jing","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2021.105136_bb0150","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.vaccine.2013.08.066","article-title":"Current status and prospects for development of an HSV vaccine","volume":"32","author":"Johnston","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.105136_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/icb.2009.13","article-title":"Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection","volume":"87","author":"Karanam","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.meegid.2021.105136_bb0160","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.vaccine.2015.02.055","article-title":"Outer membrane proteins preferentially load MHC class II peptides: implications for a chlamydia trachomatis T cell vaccine","volume":"33","author":"Karunakaran","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.105136_bb0165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1078-0432.CCR-07-1881","article-title":"Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity","volume":"14","author":"Kenter","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.meegid.2021.105136_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.meegid.2021.105136_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002829","article-title":"Reliable B cell epitope predictions: impacts of method development and improved benchmarking","volume":"8","author":"Kringelum","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.meegid.2021.105136_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.meegid.2021.105136_bb0190","doi-asserted-by":"crossref","first-page":"W254","DOI":"10.1093\/nar\/gkr434","article-title":"PAComplex: a web server to infer peptide antigen families and binding models from TCR-pMHC complexes","volume":"39","author":"Liu","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2021.105136_bb0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1574-695X.2006.00165.x","article-title":"A recombinant multivalent combination vaccine protects against chlamydia and genital herpes","volume":"49","author":"Macmillan","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.meegid.2021.105136_bb0200","first-page":"2936","article-title":"High-throughput prediction of protein antigenicity using protein microarray data","volume":"26","author":"Magnan","year":"2010","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.meegid.2021.105136_bb0205","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","article-title":"Flagellin as an adjuvant: cellular mechanisms and potential","volume":"185","author":"Mizel","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2021.105136_bb0210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.biotechadv.2017.03.005","article-title":"Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines","volume":"35","author":"Moyle","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.meegid.2021.105136_bb0215","first-page":"1","article-title":"Association between human papillomavirus and chlamydia trachomatis infection risk in women: a systematic review and meta-analysis","author":"Naldini","year":"2019","journal-title":"Int. J. Public Health"},{"key":"10.1016\/j.meegid.2021.105136_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.105136_bb0225","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<203::AID-IJC9>3.0.CO;2-9","article-title":"Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer","volume":"82","author":"Nindl","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.meegid.2021.105136_bb0230","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/ije\/29.2.344","article-title":"Behavioural and serological human immunodeficiency virus risk factors among female commercial sex workers in Cambodia","volume":"29","author":"Ohshige","year":"2000","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.meegid.2021.105136_bb0235","series-title":"Report on Global Sexually Transmitted Infection Surveillance 2018","author":"Organization","year":"2018"},{"key":"10.1016\/j.meegid.2021.105136_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00070","article-title":"Seventy years of chlamydia vaccine research \u2013 limitations of the past and directions for the future","volume":"10","author":"Phillips","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2021.105136_bb0245","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1158\/1078-0432.CCR-15-2594","article-title":"Vaccination against oncoproteins of HPV16 for noninvasive vulvar\/vaginal lesions: lesion clearance is related to the strength of the T-cell response","volume":"22","author":"van Poelgeest","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.meegid.2021.105136_bb0250","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0198-8859(02)00432-9","article-title":"Prediction of MHC class I binding peptides using profile motifs","volume":"63","author":"Reche","year":"2002","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.meegid.2021.105136_bb0255","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.meegid.2021.105136_bb0260","series-title":"Artificial Immune Systems","first-page":"197","article-title":"BcePred: Prediction of continuous B-cell epitopes in antigenic sequences using Physico-chemical properties","author":"Saha","year":"2004"},{"key":"10.1016\/j.meegid.2021.105136_bb0265","doi-asserted-by":"crossref","first-page":"W202","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"Saha","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2021.105136_bb0270","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.meegid.2021.105136_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071322","article-title":"Bicistronic DNA vaccines simultaneously encoding HIV, HSV and HPV antigens promote CD8(+) T cell responses and protective immunity","volume":"8","author":"Santana","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.105136_bb0280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2005.04.026","article-title":"HPV 16 E6 sequence variations in Indian patients with cervical neoplasia","volume":"229","author":"Sathish","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.meegid.2021.105136_bb0285","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.virusres.2016.11.020","article-title":"Developments in L2-based human papillomavirus (HPV) vaccines","volume":"231","author":"Schellenbacher","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.meegid.2021.105136_bb0290","series-title":"Immunopotentiators in Modern Vaccines","first-page":"1","article-title":"Chapter 1 - vaccine Adjuvants\u2019 mode of action: Unraveling \u201cthe immunologist\u2019s dirty little secret\u201d","author":"Schijns","year":"2017"},{"key":"10.1016\/j.meegid.2021.105136_bb0295","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-D\u2013adjuvant vaccine to prevent genital herpes","volume":"347","author":"Stanberry","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2021.105136_bb0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1552-6909.2002.tb00027.x","article-title":"Chlamydia during pregnancy: implications and impact on perinatal and neonatal outcomes","volume":"31","author":"Tiller","year":"2002","journal-title":"J. Obstet. Gynecol. Neonatal. Nurs."},{"key":"10.1016\/j.meegid.2021.105136_bb0305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jmv.20154","article-title":"Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer","volume":"74","author":"Tornesello","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2021.105136_bb0310","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1470-2045(09)70227-X","article-title":"Development of therapeutic HPV vaccines","volume":"10","author":"Trimble","year":"2009","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.meegid.2021.105136_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00373","article-title":"Mechanisms of immune control of mucosal HSV infection: a guide to rational vaccine design","volume":"10","author":"Truong","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2021.105136_bb0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/14760584.2014.865523","article-title":"Second-generation prophylactic HPV vaccines: successes and challenges","volume":"13","author":"Tyler","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.meegid.2021.105136_bb0325","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijbiomac.2018.08.125","article-title":"Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum","volume":"120","author":"Vakili","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.meegid.2021.105136_bb0330","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1016\/j.vaccine.2005.04.049","article-title":"Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model","volume":"23","author":"Vambutas","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.105136_bb0335","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/21505594.2015.1111509","article-title":"Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates","volume":"7","author":"Vasilevsky","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.meegid.2021.105136_bb0340","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2021.105136_bb0345","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2021.105136_bb0350","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.4049\/jimmunol.168.10.4998","article-title":"Optimizing the efficacy of epitope-directed DNA vaccination","volume":"168","author":"Wolkers","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2021.105136_bb0355","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1099\/vir.0.81649-0","article-title":"Analysis of mutations in the E6\/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China","volume":"87","author":"Wu","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2021.105136_bb0360","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/jvi.71.3.2463-2472.1997","article-title":"Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective","volume":"71","author":"Yamada","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2021.105136_bb0365","first-page":"10","article-title":"Efficient inhibition of human papillomavirus infection by L2 minor capsid-derived lipopeptide","author":"Yan","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.meegid.2021.105136_bb0370","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.meegid.2021.105136_bb0375","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nature12110","article-title":"Immune surveillance by CD8\u03b1\u03b1+ skin-resident T cells in human herpes virus infection","volume":"497","author":"Zhu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.105136_bb0380","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"Zur Hausen","year":"2002","journal-title":"Nat. Rev. Cancer"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821004366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821004366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:54:12Z","timestamp":1761576852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134821004366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":75,"alternative-id":["S1567134821004366"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2021.105136","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-133991\/v1","asserted-by":"object"}]},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2021.105136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105136"}}